Amblyotech (amblyotech.com): 1 change recorded in its website history since November 2026. Homepage last checked 6 November 2026.
Acquired. Its homepage says “Novartis acquires Amblyotech, pursuing novel digital therapy for children and adult patients with “lazy eye””. Seen on (already showing at the first check).
Recorded changes
Newest observations first. Each interval bounds when the website changed; it is not an exact event date.
AcquiredSeen on (already showing at the first check)
Its homepage says “Novartis acquires Amblyotech, pursuing novel digital therapy for children and adult patients with “lazy eye””.
Observed on the company’s website; business claims are not independently verified.
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
Novartis acquires Amblyotech, pursuing novel digital therapy for children and adult patients with “lazy eye”
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen November 2026 · 1 captureNovartis acquires Amblyotech, pursuing novel digital therapy for children and adult patients with “lazy eye”